- Home
- MBBC vs MIRA Comparison
MBBC vs MIRA Comparison
Compare MBBC & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBBC
- MIRA
- Stock Information
- Founded
- MBBC 1902
- MIRA 2020
- Country
- MBBC United States
- MIRA United States
- Employees
- MBBC N/A
- MIRA N/A
- Industry
- MBBC Banks
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- MBBC Finance
- MIRA Health Care
- Exchange
- MBBC Nasdaq
- MIRA Nasdaq
- Market Cap
- MBBC 30.4M
- MIRA 26.5M
- IPO Year
- MBBC N/A
- MIRA 2023
- Fundamental
- Price
- MBBC $10.28
- MIRA $1.31
- Analyst Decision
- MBBC
- MIRA Strong Buy
- Analyst Count
- MBBC 0
- MIRA 1
- Target Price
- MBBC N/A
- MIRA $17.00
- AVG Volume (30 Days)
- MBBC 4.8K
- MIRA 782.5K
- Earning Date
- MBBC 09-24-2025
- MIRA 11-11-2025
- Dividend Yield
- MBBC N/A
- MIRA N/A
- EPS Growth
- MBBC 103.56
- MIRA N/A
- EPS
- MBBC 0.22
- MIRA N/A
- Revenue
- MBBC $6,591,743.00
- MIRA N/A
- Revenue This Year
- MBBC N/A
- MIRA N/A
- Revenue Next Year
- MBBC N/A
- MIRA N/A
- P/E Ratio
- MBBC $46.54
- MIRA N/A
- Revenue Growth
- MBBC N/A
- MIRA N/A
- 52 Week Low
- MBBC $6.42
- MIRA $0.73
- 52 Week High
- MBBC $12.00
- MIRA $2.56
- Technical
- Relative Strength Index (RSI)
- MBBC N/A
- MIRA 40.97
- Support Level
- MBBC N/A
- MIRA $1.19
- Resistance Level
- MBBC N/A
- MIRA $1.72
- Average True Range (ATR)
- MBBC 0.00
- MIRA 0.10
- MACD
- MBBC 0.00
- MIRA -0.01
- Stochastic Oscillator
- MBBC 0.00
- MIRA 19.96
About MBBC Marathon Bancorp Inc. Common Stock
Marathon Bancorp Inc is a Wisconsin-chartered savings bank. It is a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the Company's revenues come from interest income on loans and debt securities.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.